AKT1 and glioblastoma: According to DAVID classification, numerous of the upregulated proteins after NDs treatment are associated with poor glioblastoma prognosis, ECM remodeling, cell motility regulation, PI3K-Akt pathway activation, and the senescence-associated secretory phenotype (SASP).